Billiontoone (NASDAQ:BLLN) Stock Price Up 8.2% – Here’s Why

Billiontoone, Inc. (NASDAQ:BLLN)’s stock price rose 8.2% during mid-day trading on Thursday . The company traded as high as $104.50 and last traded at $106.4690. Approximately 72,786 shares were traded during trading, a decline of 82% from the average daily volume of 414,616 shares. The stock had previously closed at $98.36.

Analyst Ratings Changes

A number of analysts have weighed in on the company. Guggenheim increased their price objective on Billiontoone from $100.00 to $120.00 and gave the stock a “buy” rating in a research report on Wednesday, May 13th. JPMorgan Chase & Co. increased their price objective on Billiontoone from $120.00 to $125.00 and gave the stock an “overweight” rating in a research report on Thursday, May 7th. BTIG Research decreased their price objective on Billiontoone from $140.00 to $130.00 and set a “buy” rating for the company in a research report on Thursday, May 7th. Wall Street Zen raised Billiontoone from a “hold” rating to a “buy” rating in a research report on Saturday, March 7th. Finally, Wells Fargo & Company decreased their price objective on Billiontoone from $110.00 to $90.00 and set an “equal weight” rating for the company in a research report on Thursday, March 5th. Six equities research analysts have rated the stock with a Buy rating, three have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat, Billiontoone currently has a consensus rating of “Moderate Buy” and an average target price of $125.29.

Billiontoone Stock Up 7.8%

The company has a debt-to-equity ratio of 0.18, a quick ratio of 10.58 and a current ratio of 10.92. The business has a 50-day simple moving average of $84.55 and a two-hundred day simple moving average of $88.01. The company has a market capitalization of $4.88 billion and a price-to-earnings ratio of 192.34.

Billiontoone (NASDAQ:BLLN) last posted its quarterly earnings results on Wednesday, May 6th. The company reported $0.34 EPS for the quarter, beating the consensus estimate of $0.01 by $0.33. The business had revenue of $108.39 million during the quarter, compared to analyst estimates of $95.81 million. The firm’s quarterly revenue was up 83.8% compared to the same quarter last year. During the same period in the prior year, the business earned ($0.39) earnings per share. As a group, equities analysts predict that Billiontoone, Inc. will post 0.93 EPS for the current year.

Institutional Trading of Billiontoone

Hedge funds have recently modified their holdings of the business. Rossby Financial LCC acquired a new stake in shares of Billiontoone in the 4th quarter valued at approximately $25,000. Wells Fargo & Company MN acquired a new stake in shares of Billiontoone in the 4th quarter valued at approximately $76,000. Smartleaf Asset Management LLC acquired a new stake in shares of Billiontoone in the 4th quarter valued at approximately $80,000. Nano Cap New Millennium Growth Fund L P acquired a new stake in shares of Billiontoone in the 4th quarter valued at approximately $82,000. Finally, Renaissance Capital LLC acquired a new position in Billiontoone during the fourth quarter worth $201,000.

About Billiontoone

BillionToOne (NASDAQ: BLLN) is a molecular diagnostics company that develops and commercializes high-precision genetic testing solutions based on single-molecule counting technology. The company’s platform is designed to detect and quantify rare genetic variants and chromosomal abnormalities from cell-free DNA, with a primary focus on applications in prenatal screening and other clinical genetic tests where sensitivity and specificity at very low allele fractions are critical.

BillionToOne’s offerings center on assay development and clinical testing workflows that enable non-invasive prenatal testing (NIPT) and targeted molecular diagnostics.